27 janvier 2014
Publications IICiMed 2014
P124 Defaux, J.; Antoine, M.; Le Borgne, M.; Schuster, T.; Seipelt, I.; Aicher, B.; Teifel, M.; Günther, E.; Gerlach, M.; Marchand, P. Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. ChemMedChem 2014, 9, 217-232.
P125 Montoir, D.; Tonnerre, A.; Duflos, M.; Bazin, M.-A. Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings. Eur. J. Org. Chem. 2014, 7, 1487-1495.
P126 Sakanyan, V.; Angelini, M.; Le Béchec, M.; Lecocq, M.-F.; Benaiteau, F.; Rousseau, B.; Gyulkhandanyan, A.; Gyulkhandanyan, L.; Logé, C.; Reiter, E.; Roussakis, C.; Fleury, F. Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells. Sci. Rep. 2014, 4:3977. doi: 10.1038/srep03977.
P127 Defaux, J.; Antoine, M.; Logé, C.; Le Borgne, M.; Schuster, T.; Seipelt, I.; Aicher, B.; Teifel, M.; Günther, E.; Gerlach, M.; Marchand, P. Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells. Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.
P128 Morio, F. Mutations du gène codant la Dihydroptéroate synthase (DHPS) et résistance aux traitements anti-Pneumocystis : Mythe ou réalité ? Journal des Anti-infectieux. 2014.
P129 Morio, F.; Le Pape, P. Mécanismes de la résistance des Candida aux antifongiques. Actualités permanentes en Microbiologie Clinique. 2014.
P130 Palmisano, A.; Morio, F.; Le Pape, P.; Degli Antoni A. M., Ricci, R.; Zucchi, A.; Vaglio, A.; Piotti, G.; Antoniotti, R.; Cremaschi, E.; Buzio, C.; Maggiore, U. Multifocal phaeohyphomycosis caused by Exophiala xenobiotica in a kidney transplant recipient. Transpl. Infect. Dis. 2014.
P131 Bruel, A.; Bénéteau, R.; Chabanne, M.; Lozach, O.; Le Guével, R.; Ravache, M.; Bénédetti, H.; Meijer, L.; Logé, C.; Robert, J.-M. Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors. Bioorg. Med. Chem. Lett. 2014, 24, 5037-5040.
P132 Ronga, L; Del Favero, M.; Cohen, A.; Soum, C.; Le Pape, P.; Savrimoutou, S.; Pinaud, N.; Mullié, C.; Daulouede, S.; Vincendeau, P.; Farvacques, N.; Agnamey, P.; Pagniez, P.; Hutter, S.; Azas, N.; Sonnet, P.; Guillon, J. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents - Part III. Eur. J. Med. Chem. 2014, 81, 378-393.
P133 Jacquot, C; Rousseau, B; Carbonnelle, D; Chinou, I; Malleter, M; Tomasoni, C; Roussakis, C. Cucurbitacin-D-induced CDK1 mRNA Up-regulation Causes Proliferation Arrest of a Non-small Cell Lung Carcinoma Cell Line (NSCLC-N6). Anticancer Res. 2014, 34, 4797-4806.
P134 Aoun, V.; Duval, C.; Pagniez, F.; Rabanel, J.-M.; Le Pape, P.; Roullin, V. G.; Leclair, G.; Hildgen, P. Enhanced pulmonary administration of amphotericin B loaded in PEG-g-PLA nanoparticles: in vitro proof-of-concept and susceptibility against Candida spp. and Aspergillus spp. J. Nanopharmaceutics Drug Delivery 2014, 2, 1-11.
P125 Montoir, D.; Tonnerre, A.; Duflos, M.; Bazin, M.-A. Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings. Eur. J. Org. Chem. 2014, 7, 1487-1495.
P126 Sakanyan, V.; Angelini, M.; Le Béchec, M.; Lecocq, M.-F.; Benaiteau, F.; Rousseau, B.; Gyulkhandanyan, A.; Gyulkhandanyan, L.; Logé, C.; Reiter, E.; Roussakis, C.; Fleury, F. Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells. Sci. Rep. 2014, 4:3977. doi: 10.1038/srep03977.
P127 Defaux, J.; Antoine, M.; Logé, C.; Le Borgne, M.; Schuster, T.; Seipelt, I.; Aicher, B.; Teifel, M.; Günther, E.; Gerlach, M.; Marchand, P. Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells. Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.
P128 Morio, F. Mutations du gène codant la Dihydroptéroate synthase (DHPS) et résistance aux traitements anti-Pneumocystis : Mythe ou réalité ? Journal des Anti-infectieux. 2014.
P129 Morio, F.; Le Pape, P. Mécanismes de la résistance des Candida aux antifongiques. Actualités permanentes en Microbiologie Clinique. 2014.
P130 Palmisano, A.; Morio, F.; Le Pape, P.; Degli Antoni A. M., Ricci, R.; Zucchi, A.; Vaglio, A.; Piotti, G.; Antoniotti, R.; Cremaschi, E.; Buzio, C.; Maggiore, U. Multifocal phaeohyphomycosis caused by Exophiala xenobiotica in a kidney transplant recipient. Transpl. Infect. Dis. 2014.
P131 Bruel, A.; Bénéteau, R.; Chabanne, M.; Lozach, O.; Le Guével, R.; Ravache, M.; Bénédetti, H.; Meijer, L.; Logé, C.; Robert, J.-M. Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors. Bioorg. Med. Chem. Lett. 2014, 24, 5037-5040.
P132 Ronga, L; Del Favero, M.; Cohen, A.; Soum, C.; Le Pape, P.; Savrimoutou, S.; Pinaud, N.; Mullié, C.; Daulouede, S.; Vincendeau, P.; Farvacques, N.; Agnamey, P.; Pagniez, P.; Hutter, S.; Azas, N.; Sonnet, P.; Guillon, J. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents - Part III. Eur. J. Med. Chem. 2014, 81, 378-393.
P133 Jacquot, C; Rousseau, B; Carbonnelle, D; Chinou, I; Malleter, M; Tomasoni, C; Roussakis, C. Cucurbitacin-D-induced CDK1 mRNA Up-regulation Causes Proliferation Arrest of a Non-small Cell Lung Carcinoma Cell Line (NSCLC-N6). Anticancer Res. 2014, 34, 4797-4806.
P134 Aoun, V.; Duval, C.; Pagniez, F.; Rabanel, J.-M.; Le Pape, P.; Roullin, V. G.; Leclair, G.; Hildgen, P. Enhanced pulmonary administration of amphotericin B loaded in PEG-g-PLA nanoparticles: in vitro proof-of-concept and susceptibility against Candida spp. and Aspergillus spp. J. Nanopharmaceutics Drug Delivery 2014, 2, 1-11.
Mis à jour le 24 septembre 2015 par Céline LHOMELET.